Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the ﬁbrocytic myeloid-derived suppressor cells in an m6A-dependent manner-Reference-Cited by-同舟云学术

Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the ﬁbrocytic myeloid-derived suppressor cells in an m6A-dependent manner

Published:2021-09 Issue: Volume:137 Page:28-40
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Mu Xingyu,Wu Ke,Zhu Yiwen,Zhu Youjia,Wang Yong,Xiao Liang,Yao Zhixian,Huang Wenjie,Sun Feng,Fan Jie,Zheng Zhong,Liu Zhihong

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference33 articles.

1. A role for G-CSF and GM-CSF in nonmyeloid cancers;Aliper;Cancer Med.,2014

2. Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain;Amort;Genome Biol.,2017

3. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur. Urol.,2017

4. Shaping of an effective immune microenvironment to and by cancer cells;Becht;Cancer Immunol. Immunother.,2014

5. Tumor eradication by cisplatin is sustained by CD80/86-mediated costimulation of CD8+ t cells;Beyranvand Nejad;Cancer Res.,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications;Frontiers in Immunology;2024-01-22

2. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles;Environmental Research;2024-01

3. RNA m6A modifications regulate crosstalk between tumor metabolism and immunity;WIREs RNA;2023-12-19

4. m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy;Frontiers in Immunology;2023-12-15

5. The current landscape of m6A modification in urological cancers;PeerJ;2023-09-07